Dr. Manasanch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd, Unit 429
Houston, TX 77030Phone+1 713-792-6161
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2010 - 2014
UMass Chan Medical SchoolResidency, Internal Medicine, 2007 - 2010
Universidad de Barcelona Faculty of MedicineClass of 2005
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2025
GA State Medical License 2023 - 2024
MS State Medical License 2023 - 2024
OK State Medical License 2020 - 2024
TN State Medical License 2023 - 2024
TX State Medical License 2013 - 2024- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Medical Oncology
- Join now to see all
Clinical Trials
- Isatuximab With or Without Lenalidomide in Patients With High Risk Smoldering Multiple Myeloma (ISAMAR) Start of enrollment: 2017 Feb 08
- Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple Myeloma Start of enrollment: 2017 Oct 01
- Personalized Vaccine in Treating Patients With Smoldering Multiple Myeloma Start of enrollment: 2018 Dec 21
Publications & Presentations
PubMed
- 638 citationsProteasome inhibitors in cancer therapyElisabet E. Manasanch, Robert Z. Orlowski
Nature Reviews. Clinical Oncology. 2017-01-24 - 100 citationsA phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myelomaNeha Korde, Mattias Carlsten, Min-Jung Lee, Alex Minter, Esther Tan
Haematologica. 2014-06-01 - 242 citationsTreatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma.Neha Korde, Mark Roschewski, Adriana Zingone, Mary Kwok, Elisabet E. Manasanch
JAMA Oncology. 2015-09-01
Journal Articles
- Primary Plasma Cell Leukemia: Autologous Stem Cell Transplant in an Era of Novel Induction DrugsKrina Patel, Rohtesh Mehta, Donna M Weber, Sheeba K Thomas, Nina Shah, Hans C Lee, Elisabet E Manasanch, Muzaffar H Qazilbash, Qaiser Bashir, Simrit Parmar, Robert Z O..., Nature
Abstracts/Posters
- A Multicenter Phase II Single Arm Trial of Isatuximab in Patients with High Risk Smoldering Multiple Myeloma (HRSMM)Elisabet E. Manasanch, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Outcomes of Lenalidomide Retreatment with Novel Triplet Regimens in Multiple Myeloma Patients Progressing on Lenalidomide-Based Maintenance Therapy: A Single Center Re...Elisabet E. Manasanch, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- T Cells Expressing an Anti-B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor with a Fully-Human Heavy-Chain-Only Antigen Recognition Domain Induce Remissions ...Elisabet E. Manasanch, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- A Multicenter Phase II Single Arm Trial of Isatuximab in Patients with High Risk Smoldering Multiple Myeloma (HRSMM)61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Challenges in Myeloma Therapy61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Older Age As a Prognostic Factor for Overall Survival for Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
Telo Genomics Forms World-Class Multiple Myeloma Advisory Board in Preparation for the American Society of Hematology Annual MeetingDecember 8th, 2022- Burning Questions About Smouldering MyelomaNovember 25th, 2020
Once Quickly Lethal and Still Humbling, Multiple Myeloma May Be in a ‘Golden Age’ of TreatmentMay 29th, 2018- Join now to see all
External Links
- MD Anderson Cancer Centerhttp://faculty.mdanderson.org/Elisabet_Manasanch/Default.asp
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
